Photos: India logs 16,504 new Covid-19 cases as vaccines cleared for use

UPDATED ON JAN 04, 2021 06:06 PM IST
A health worker collects a swab sample from a woman to test for coronavirus infection at Malad (West) in Mumbai on January 3. India recorded 16,504 cases of the coronavirus disease (Covid-19) and 214 related deaths between January 3 and 4 morning, according to the Union ministry of health and family welfare. (Satyabrata Tripathy / HT Photo)
People jogging at Lodhi Garden in New Delhi on January 4. According to the health ministry, 9,946,867 people have recovered until now with 19,557 patients of Covid-19 cured or discharged across the country in the previous 24 hour period. (Adnan Abidi / REUTERS)
A health worker interacts with a candidate during a Covid-19 vaccine dry run drive at District Hospital, in Aundh, Pune on January 2. The national recovery rate has risen to 96.19% and the gap between recovered and active cases has widened further to 9,702,914. Daily new recoveries have outpaced daily cases over the last 38 days. (Pratham Gokhale / HT Photo)
A view showing the entry and exit gates of Delhi’s first Covid-19 vaccination centre set up in Daryaganj on January 1. The Drugs Controller General of India (DCGI) on January 3 approved the Oxford University-AstraZeneca Plc. Covid-19 vaccine, Covishield, and Bharat Biotech International Limited’s Covaxin for restricted emergency use, clearing the way for the government’s vaccination drive in about 10 days. (Amal KS / HT Photo)
A health worker holds a vial during a dry run of the Covid-19 vaccination programme, at Guru Teg Bahadur Hospital in New Delhi on January 2. While there has been criticism from a large section of experts about the way approvals were given without adequate efficacy data, some experts say there is a provision for such approvals in the Indian regulatory system during emergency situations such as a pandemic. (Raj K Raj / HT Photo)
A health worker during a dry run of Covid-19 vaccination programme at a health centre in New Delhi on January 2. Serum Institute of India’s Adar Poonawalla told Associated Press that the government will not allow the export of the Oxford-AstraZeneca vaccine for several months. “We can only give (the vaccines) to the government of India at the moment,” Poonawalla said, adding the decision was also made to prevent hoarding. (Sanchit Khanna / HT Photo)
A doctor administers a mock Covid-19 vaccine during a dry run programme at Govt Rajindra Hospital in Patiala on January 3. Poonawalla also said the first 100 million doses of the vaccine were being sold to the government at a special price of ₹200 per dose, after which prices would be higher. (Bharat Bhushan / HT Photo)
A man applies finishing touches to graffiti representing a vaccine, in Kolkata on January 2. The vaccine will be sold on the private market at ₹1,000, Poonawalla told AP. He said vaccines could be delivered to states where they were needed within seven to ten days of the company finalising a deal with the Centre. (Rupak De Chowdhuri / REUTERS)

A health worker collects a swab sample from a woman to test for coronavirus infection at Malad (West) in Mumbai on January 3. India recorded 16,504 cases of the coronavirus disease (Covid-19) and 214 related deaths between January 3 and 4 morning, according to the Union ministry of health and family welfare. (Satyabrata Tripathy / HT Photo)

People jogging at Lodhi Garden in New Delhi on January 4. According to the health ministry, 9,946,867 people have recovered until now with 19,557 patients of Covid-19 cured or discharged across the country in the previous 24 hour period. (Adnan Abidi / REUTERS)

A health worker interacts with a candidate during a Covid-19 vaccine dry run drive at District Hospital, in Aundh, Pune on January 2. The national recovery rate has risen to 96.19% and the gap between recovered and active cases has widened further to 9,702,914. Daily new recoveries have outpaced daily cases over the last 38 days. (Pratham Gokhale / HT Photo)

A view showing the entry and exit gates of Delhi’s first Covid-19 vaccination centre set up in Daryaganj on January 1. The Drugs Controller General of India (DCGI) on January 3 approved the Oxford University-AstraZeneca Plc. Covid-19 vaccine, Covishield, and Bharat Biotech International Limited’s Covaxin for restricted emergency use, clearing the way for the government’s vaccination drive in about 10 days. (Amal KS / HT Photo)

A health worker holds a vial during a dry run of the Covid-19 vaccination programme, at Guru Teg Bahadur Hospital in New Delhi on January 2. While there has been criticism from a large section of experts about the way approvals were given without adequate efficacy data, some experts say there is a provision for such approvals in the Indian regulatory system during emergency situations such as a pandemic. (Raj K Raj / HT Photo)

A health worker during a dry run of Covid-19 vaccination programme at a health centre in New Delhi on January 2. Serum Institute of India’s Adar Poonawalla told Associated Press that the government will not allow the export of the Oxford-AstraZeneca vaccine for several months. “We can only give (the vaccines) to the government of India at the moment,” Poonawalla said, adding the decision was also made to prevent hoarding. (Sanchit Khanna / HT Photo)

A doctor administers a mock Covid-19 vaccine during a dry run programme at Govt Rajindra Hospital in Patiala on January 3. Poonawalla also said the first 100 million doses of the vaccine were being sold to the government at a special price of ₹200 per dose, after which prices would be higher. (Bharat Bhushan / HT Photo)

A man applies finishing touches to graffiti representing a vaccine, in Kolkata on January 2. The vaccine will be sold on the private market at ₹1,000, Poonawalla told AP. He said vaccines could be delivered to states where they were needed within seven to ten days of the company finalising a deal with the Centre. (Rupak De Chowdhuri / REUTERS)

About The Gallery

India logged 16,504 cases of the coronavirus disease (Covid-19) and 214 related deaths on January 3, data from the health ministry shows. The national recovery rate in the latest health update has gone up to 96.19%. India’s current Covid-19 tally stands at 10,340,469 cases with 9,946,867 recoveries and 149,649 deaths. Also on January 3, the Drugs Controller General of India (DCGI) approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin Covid-19 vaccine candidates for restricted emergency use, learin the way for a mass vaccination programme in the country.

[OTHER GALLERIES]

SHARE
Story Saved